MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 18.03.2026
Marker Therapeutics Kurzfristige Verbindlichkeiten 2011-2026 | MRKR
Kurzfristige Verbindlichkeiten Jährlich Marker Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.27 M | 3.46 M | 3.07 M | 7.78 M | 12.9 M | 6.4 M | 1.99 M | 2.8 M | 1.52 M | 1.74 M | 28 M | 1.25 M | 8.85 M | 5.77 M | 3.8 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 28 M | 1.25 M | 6.11 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Compugen Ltd.
CGEN
|
22.6 M | $ 2.86 | 3.62 % | $ 267 M |  Israel |
 |
AgeX Therapeutics
AGE
|
3.56 M | - | -10.17 % | $ 12.2 K |  USA |
 |
I-Mab
IMAB
|
576 M | - | - | $ 866 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
1.62 B | - | - | $ 40.3 B | USA |
 |
Enlivex Therapeutics Ltd.
ENLV
|
9.02 M | $ 0.8 | -3.59 % | $ 36.6 M | Israel |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.77 M | - | -1.52 % | $ 24.7 M | USA |
 |
Athira Pharma
ATHA
|
47.5 M | - | - | $ 269 M | USA |
 |
Exelixis
EXEL
|
406 M | $ 46.21 | -5.11 % | $ 12.5 B | USA |
 |
Fortress Biotech
FBIO
|
49.7 M | $ 2.4 | -5.88 % | $ 67 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
556 M | - | - | - |  Russia |
|
Forte Biosciences
FBRX
|
20.8 M | $ 26.17 | -1.32 % | $ 339 M | USA |
 |
Checkmate Pharmaceuticals
CMPI
|
9.38 M | - | - | $ 231 M | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
395 M | $ 22.56 | 5.03 % | $ 3.74 B | USA |
 |
Advaxis
ADXS
|
25 M | - | -9.65 % | $ 45.9 M | USA |
 |
Esperion Therapeutics
ESPR
|
301 M | $ 3.14 | -0.32 % | $ 653 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.73 M | $ 3.54 | 3.51 % | $ 5.83 M | Israel |
 |
Genprex
GNPX
|
2.17 M | $ 0.87 | -2.84 % | $ 811 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
58.7 M | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
25.2 M | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
1.61 M | - | 1.93 % | $ 17.4 M | USA |
 |
Akero Therapeutics
AKRO
|
39.8 M | - | - | $ 3.67 B | USA |
 |
Aptose Biosciences
APTO
|
9.31 M | - | -45.71 % | $ 1.2 M |  Canada |
 |
Aptinyx
APTX
|
6.29 M | - | -39.0 % | $ 4.57 M | USA |
 |
Akouos
AKUS
|
16.8 M | - | 0.23 % | $ 488 M | USA |
 |
Albireo Pharma
ALBO
|
45.3 M | - | -0.23 % | $ 916 M | USA |
 |
Allakos
ALLK
|
36.6 M | - | - | $ 28.6 M | USA |
 |
AlloVir
ALVR
|
9.71 M | - | 4.14 % | $ 49.1 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
130 M | $ 20.66 | -14.52 % | $ 2.63 B | USA |
 |
Allena Pharmaceuticals
ALNA
|
15.7 M | - | 3.16 % | $ 1.9 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
2.38 M | - | -11.43 % | $ 502 K | USA |
|
Applied Molecular Transport
AMTI
|
15.1 M | - | - | $ 10.1 M | USA |
 |
Alpine Immune Sciences
ALPN
|
58 M | - | - | $ 2.17 B | USA |
 |
Aileron Therapeutics
ALRN
|
6.18 M | - | 10.36 % | $ 9.8 M | USA |
 |
Applied Therapeutics
APLT
|
71.2 M | - | - | $ 8.42 M | USA |
 |
Aravive
ARAV
|
22.1 M | - | -13.39 % | $ 1.45 M | USA |
 |
Aridis Pharmaceuticals
ARDS
|
36.9 M | - | 17.91 % | $ 11.1 M | USA |
 |
CRISPR Therapeutics AG
CRSP
|
149 M | $ 52.42 | -4.83 % | $ 4.71 B |  Schweiz |
 |
Avenue Therapeutics
ATXI
|
1.1 M | - | -52.27 % | $ 4.45 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
73.4 M | $ 1.61 | -5.29 % | $ 428 M |  Britain |
 |
Heron Therapeutics
HRTX
|
96.1 M | $ 1.24 | -5.34 % | $ 207 M | USA |
 |
AVROBIO
AVRO
|
6.35 M | - | 1083.1 % | $ 745 M | USA |